TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Life Science Byrån LSB AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
974
|
1,007
|
1,087 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
289
|
366
|
441 |
| EBITDA |
283
|
366
|
441 |
| Total assets |
973
|
949
|
900 |
| Current assets |
771
|
829
|
857 |
| Current liabilities |
137
|
144
|
137 |
| Equity capital |
788
|
757
|
711 |
| - share capital |
34
|
33
|
36 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
81.0%
|
79.8%
|
79.0% |
| Turnover per employee |
974
|
1,007
|
1,087 |
| Profit as a percentage of turnover |
29.7%
|
36.3%
|
40.6% |
| Return on assets (ROA) |
29.7%
|
38.6%
|
49.0% |
| Current ratio |
562.8%
|
575.7%
|
625.5% |
| Return on equity (ROE) |
36.7%
|
48.3%
|
62.0% |
| Change turnover |
-38
|
8
|
85 |
| Change turnover % |
-4%
|
1%
|
8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.